(3aR,6aS)-5-[(4S)-4-amino-4-carboxybutanoyl]-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,2]oxazole-3-carboxylic acid
C11H15N3O6 — CID 127037661
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3aR,6aS)-5-[(4S)-4-amino-4-carboxybutanoyl]-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,2]oxazole-3-carboxylic acid
(3aR,6aS)-5-[(4S)-4-amino-4-carboxybutanoyl]-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,2]oxazole-3-carboxylic acid (PubChem CID 127037661) has the molecular formula C11H15N3O6 and a molecular weight of 285.26 g/mol. Its IUPAC name is (3aR,6aS)-5-[(4S)-4-amino-4-carboxybutanoyl]-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,2]oxazole-3-carboxylic acid.
Molecular Properties
| Compound Name | (3aR,6aS)-5-[(4S)-4-amino-4-carboxybutanoyl]-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,2]oxazole-3-carboxylic acid |
|---|---|
| PubChem CID | 127037661 |
| Molecular Formula | C11H15N3O6 |
| Molecular Weight | 285.26 g/mol |
| Exact Mass | 285.10 |
| IUPAC Name | (3aR,6aS)-5-[(4S)-4-amino-4-carboxybutanoyl]-3a,4,6,6a-tetrahydropyrrolo[3,4-d][1,2]oxazole-3-carboxylic acid |
| SMILES | N[C@@H](CCC(=O)N1C[C@@H]2C(C(=O)O)=NO[C@@H]2C1)C(=O)O |
| InChI | InChI=1S/C11H15N3O6/c12-6(10(16)17)1-2-8(15)14-3-5-7(4-14)20-13-9(5)11(18)19/h5-7H,1-4,12H2,(H,16,17)(H,18,19)/t5-,6-,7+/m0/s1 |
| InChIKey | VGUGMBYMNOAWGC-LYFYHCNISA-N |
| XLogP | -1.52 |
| TPSA | 142.52 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 285.26 |
| LogP ≤ 5 | -1.52 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 127037661 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.